MCW Microbiology and Molecular Genetics News

Please wait while we gather your results.

Dr. Zahrt Receives $420,000 NIH Grant to Study Therapeutic Targets for Tuberculosis

Feb. 18 - Thomas Zahrt, PhD received a two-year, $420,000 grant from the National Institute of Allergy and Infectious Disease to study new therapeutic targets for tuberculosis. Wauwatosa Now

Researcher to investigate causes of TB infection

Feb. 10 - The Medical College of Wisconsin (MCW) has received a two-year, $420,000 grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to study new therapeutic targets for tuberculosis.

Dr. William Jackson edits new book on the roles of cellular autophagy during microbial infection

Jan. 26 - William T. Jackson, PhD, Assistant Professor of Microbiology and Molecular Genetics, served as editor of a new book titled, Autophagy, Infection and the Immune Response.

Business startups to watch

Nov. 4 - The Milwaukee Journal Sentinel named Protein Foundry one of ten startups with great potential in southeast Wisconsin. Protein Foundry was founded by Brian Volkman, PhD, professor of biochemistry; and Michael Dwinell, PhD, associate professor of microbiology and molecular genetics. Milwaukee Journal

MCW committed to fighting pancreatic cancer

Oct. 3 - US Airways Magazine featured the Froedtert & the Medical College of Wisconsin Cancer Center in its new magazine. US Airways Magazine

Drs. Dwinell and Kalyanaraman Receive $2.6 Million NCI Grant to Study Pancreatic Cancer

July 29 - Michael Dwinell, PhD and Balaraman Kalyanaraman, PhD received a five-year, $2.6 million grant from the National Cancer Institute to conduct research on new therapeutic approaches for pancreatic cancer treatment. Biz Times

$2.6 Million NIH Grant Awarded to Study New Treatment Approaches for Pancreatic Cancer

Michael Dwinell, PhD and Balaraman Kalyanaraman, PhD received a five-year, $2.6 million grant from the National Cancer Institute to study new therapeutic approaches to treat pancreatic cancer. Wauwatosa Now

Four MCW Scientists Create Spin-Off Company to Manufacture and Market Protein Molecules

July 16 - Four MCW scientists have created Protein Foundry, a new spin-off company that will manufacture and market protein molecules. The company’s founders are: Brian Volkman, PhD, Chad Koplinski, and Francis Peterson, PhD, and Michael Dwinell, PhD. Milwaukee Journal Sentinel and BizTimes

Protein Foundry, a new company, launches at MCW

July 11 - Protein Foundry, a new company manufacturing and marketing protein molecules, had its official launch Thursday, July 10, at the Medical College of Wisconsin.

Dr. Jackson Receives $2.2 Million NIH Grant to Study How Viruses Become Infectious

June 10 - William Jackson, PhD received a five-year, $2.2 million grant from the National Institute of Allergy and Infectious Disease to study the ways in which specific viruses become infectious. Wauwatosa Now

Wisconsin Breast Cancer Showhouse Awards Grants to Three Researchers

June 10 - The Wisconsin Breast Cancer Showhouse awarded three MCW and BloodCenter of Wisconsin researchers with two-year, $100,000 grants to study breast cancer risks and potential new therapies. Wauwatosa Now

Researcher to study the conversion from harmless viral particles to disease-causing viruses

June 04 - The Medical College of Wisconsin has received a five-year, $2.2 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Disease to study the ways in which specific viruses become infectious.

Media Contacts

Maureen Mack
Director of External Communications
(414) 955-4744 (Office)
(414) 750-5266 (Cell)
media@mcw.edu

Richard N. Katschke
Associate Vice President
(414) 955-4748
rkatschk@mcw.edu

Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 955-8296
Directions & Maps
© 2015

Page Updated 10/05/2014
Top